MedTrace Logo

Efficacy and Safety Study of Endoscopic Submucosal Dissection for Early Gastric Cancer

NCT01132469 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1158

Last updated 2010-05-28

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and clinical effectiveness of ESD(Endoscopic Submucosal Dissection) for early gastric cancer analyzing short-term and long-term results of endoscopic treatment.

Conditions

  • Endoscopic Submucosal Dissection
  • Early Gastric Cancer
  • Multi-center, Single-arm Clinical Trial
  • Historical Control Group
  • Quality of Life and Cost Analysis

Interventions

PROCEDURE

Endoscopic Submucosal Dissection

5-years follow-up after Endoscopic Submucosal Dissection

Sponsors & Collaborators

  • National Evidence-Based Healthcare Collaborating Agency

    lead OTHER_GOV

Principal Investigators

  • Sang-Yong Seol, M.D. · Inje University College of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2016-12-31
Completion
2017-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01132469 on ClinicalTrials.gov